Mersana Therapeutics (MRSN) Q1 2025 Earnings

3MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.2
-0.16
-0.13
-0.09

Details

Expected EPS
-0.160107
Actual EPS
-0.11
Surprise EPS
0.05
Surprise Percent
+31.3%

Description

Mersana Therapeutics (MRSN) has reported earnings of -0.11 per share for Q1 2025.

0 Comments

Share your thoughts